Insiders Korro Bio, Inc.

Equities

KRRO

US5009461089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
60.95 ^USD	-3.15%		-10.87%	+27.16%

Apr. 24	Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	MT
Apr. 24	Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing	Apr. 24	MT
Korro Bio, Inc. Appoints Rachel Meyers as Board of Directors, Member of Nominating and Corporate Governance Committee	Nov. 28	CI
Frequency Therapeutics, Inc. Announces the Resignation of Christopher Loose as Chief Scientific Officer	23-07-31	CI
Frequency Therapeutics, Inc. Announces Board Changes	23-05-10	CI
Frequency Therapeutics, Inc. Appoints Christopher Loose, Ph.D., as Interim Chief Executive Officer	23-02-13	CI
Frequency Therapeutics, Inc. Announces Stepping Down of Carl P. Lebel, Ph.D. as Chief Development Officer, Effective March 31, 2023	23-02-13	CI
Actinogen Medical Appoints Medical Chief	23-01-31	MT
Voyager Therapeutics Names Peter Pfreundschuh Finance Chief	22-09-07	MT
Frequency Therapeutics, Inc. Appoints Kevin Franck as Senior Vice President of Strategic Marketing and New Product Planning	21-02-08	CI
Frequency Therapeutics Appoints Quentin McCubbin, Ph.D., as Chief Manufacturing Officer	21-01-19	CI
Frequency Therapeutics Appoints Peter Pfreundschuh as Chief Financial Officer	20-12-01	CI
Frequency Therapeutics Appoints Cynthia Feldmann to Its Board of Directors	20-09-25	CI
Frequency Therapeutics : Expands Leadership Team with Newly Appointed Chief People Officer and Head of Intellectual Property	20-02-10	AQ
Frequency Therapeutics : Expands Leadership Team with Newly Appointed Chief People Officer and Head of Intellectual Property	20-02-07	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Korro Bio, Inc.

Equities

KRRO

US5009461089

Insiders

Filters